Testing effectiveness (Phase 2)Ended earlyNCT00761436What this trial is testingPilot Study of Safety and Efficacy of SpheramineWho this might be right forParkinson''s Disease Bayer 6
Post-approval studies (Phase 4)Study completedNCT01494532What this trial is testingA Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's DiseaseWho this might be right forParkinson Disease GlaxoSmithKline 352
Not applicableWithdrawnNCT01218919What this trial is testingPost Market (Brio™ System) Deep Brain Stimulation (DBS) PD StudyWho this might be right forParkinson Disease Abbott Medical Devices
Large-scale testing (Phase 3)Study completedNCT00357994What this trial is testingStudy of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsWho this might be right forAdvanced Parkinson's Disease AbbVie (prior sponsor, Abbott) 36
Early research (Phase 1)Study completedNCT01484990What this trial is testingA Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's DiseaseWho this might be right forParkinson Disease AbbVie 19
Early research (Phase 1)Study completedNCT03065192What this trial is testingSafety and Efficacy Study of VY-AADC01 for Advanced Parkinson's DiseaseWho this might be right forIdiopathic Parkinson's DiseaseParkinson's DiseaseBasal Ganglia Disease+6 more Neurocrine Biosciences 16
Large-scale testing (Phase 3)Study completedNCT02549092What this trial is testingExamine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)Who this might be right forAdvanced Parkinson's Disease AbbVie 89
Not applicableStudy completedNCT00552474What this trial is testingDeep Brain Stimulation to Treat Symptoms of Parkinson's DiseaseWho this might be right forParkinson DiseaseMovement Disorders Abbott Medical Devices 136
Early research (Phase 1)Study completedNCT04630860What this trial is testingEvaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PDWho this might be right forParkinson Disease Luye Pharma Group Ltd. 30
Large-scale testing (Phase 3)Study completedNCT01130493What this trial is testingCompare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066Who this might be right forParkinson's Disease Impax Laboratories, LLC 110
Not applicableLooking for participantsNCT06916507What this trial is testingStudy to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)Who this might be right forParkinson's Disease AbbVie 125
Large-scale testing (Phase 3)Study completedNCT00501969What this trial is testingAn Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's DiseaseWho this might be right forAdvanced Stage Parkinson's Disease UCB Pharma 395
Post-approval studies (Phase 4)Ended earlyNCT01519882What this trial is testingSleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's DiseaseWho this might be right forAdvanced Idiopathic Parkinson's Disease UCB Pharma SA 1
Not applicableLooking for participantsNCT07467460What this trial is testingPrecision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.Who this might be right forPARKINSON DISEASE (Disorder)Alzheimer s DiseaseDiabete Type 2 Neuromed IRCCS 500
Large-scale testing (Phase 3)WithdrawnNCT03462043What this trial is testingA Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral SuspensionWho this might be right forParkinson NeuroDerm Ltd.
Not applicableUnknownNCT02274324What this trial is testingDietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s DiseaseWho this might be right forParkinson Disease Sheba Medical Center 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04750226What this trial is testingStudy To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseWho this might be right forParkinson's Disease (PD) AbbVie 118
Large-scale testing (Phase 3)Study completedNCT00335153What this trial is testingLevodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseWho this might be right forAdvanced Parkinson's Disease AbbVie (prior sponsor, Abbott) 354
Not applicableUnknownNCT03406754What this trial is testingMulti-disciplinary Rehabilitation Program for Advanced Parkinson's Patients in the CommunityWho this might be right forParkinson's Disease Tel-Aviv Sourasky Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00660673What this trial is testingOpen Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's DiseaseWho this might be right forAdvanced Parkinson's Disease AbbVie 262